Table 2.

Distributions of SUVmax

Qualitative evaluation of PET2
Outcome at latest follow-up
Negative
Positive
No progression
Progression
SUVmax, g/mL, median (range)   3.00 (1.5-4.7)   6.30 (3.0-26.8)   2.95 (1.5-4.7)   5.90 (3.1-26.8)  
SUVmax less than 3, no. of patients   21   0   21   0  
3 ≤ SUVmax less than 4, no. of patients   17   1   16   2  
4 ≤ SUVmax less than 5, no. of patients   4   1   4   1  
SUVmax greater than or equal to 5, no. of patients
 		 0
 		 6
 		 0
 		 6
 
Qualitative evaluation of PET2
Outcome at latest follow-up
Negative
Positive
No progression
Progression
SUVmax, g/mL, median (range)   3.00 (1.5-4.7)   6.30 (3.0-26.8)   2.95 (1.5-4.7)   5.90 (3.1-26.8)  
SUVmax less than 3, no. of patients   21   0   21   0  
3 ≤ SUVmax less than 4, no. of patients   17   1   16   2  
4 ≤ SUVmax less than 5, no. of patients   4   1   4   1  
SUVmax greater than or equal to 5, no. of patients
 		 0
 		 6
 		 0
 		 6
 
View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal